Wednesday, July 8, 2026

pharma · Colorectal Cancer · Cancer · GDTC

CytoMed Therapeutics

CytoMed Therapeutics patent portfolio — 3 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

1 COMMONWEALTH LANE, U0, SG HQ
2018 Founded
26 Employees
Public company Type
GDTC · NYSE Ticker
Company details
Status
Public
HQ
1 COMMONWEALTH LANE, U0, SG
Founded
2018
Employees
26
Programs
4
Drugs
12
Patents
3
Intelligence · Patents

CytoMed Therapeutics patents

3 pharmaceutical patents indexed for CytoMed Therapeutics. 1 expire within 24 months.

CytoMed Therapeutics has 3 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 1 expire within 24 months — use filters for patent-cliff planning.

Patent portfolio

  1. US 7112342

    Enriched platelet wound healant

    Expires Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 6524568

    Enriched platelet wound healant

    Expires Mon Feb 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired
  3. US 6294574

    Compounds and methods for the treatment of inflammatory and immune disorders

    Expires Mon Sep 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does CytoMed Therapeutics have?

3 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do CytoMed Therapeutics patents expire?

1 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.